Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

EGX:MCRO Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	479.9	176.04	62.34	75.31	186.75	60.67
Cash & Short-Term Investments	479.9	176.04	62.34	75.31	186.75	60.67
Cash Growth	338.35%	182.39%	-17.22%	-59.67%	207.81%	1.07%
Accounts Receivable	60.79	43.26	76.67	38.76	244.24	184.88
Receivables	383.04	269.88	298.13	164.96	368.33	337.9
Inventory	159.39	99.76	103.06	141.56	138.73	65.62
Prepaid Expenses	-	-	-	-	-	0.99
Other Current Assets	88.23	81.32	50.75	41.91	38.69	10.89
Total Current Assets	1,111	627	514.27	423.74	732.51	476.07
Property, Plant & Equipment	126.88	123.95	74.02	62.74	64.91	54.33
Goodwill	25.28	25.28	25.28	25.28	46.7	46.7
Other Intangible Assets	1.21	1.43	1.46	1.93	5.52	-
Total Assets	1,264	777.66	615.03	513.69	849.63	577.1

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	102.83	59.59	31.47	53.76	21.82	13.61
Accrued Expenses	149.99	88.15	120.85	81.57	79.93	47.92
Short-Term Debt	-	200.76	144.16	198.29	176.77	82.99
Current Portion of Leases	12.27	13.08	17.08	4.99	7.24	3.56
Current Income Taxes Payable	0.21	1.04	1.15	0.29	51.88	42.24
Other Current Liabilities	138.12	100.59	67.14	55.14	28.41	15.71
Total Current Liabilities	403.42	463.22	381.86	394.04	366.06	206.03
Long-Term Debt	-	86.03	138.77	-	-	-
Long-Term Leases	37.76	33.55	16.3	22.9	20.63	11.26
Long-Term Deferred Tax Liabilities	0.94	0.94	-	2.42	-	1.88
Total Liabilities	442.12	583.74	536.93	419.36	386.69	219.17

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	684.25	114.04	114.04	114.04	115.47	115.47
Retained Earnings	132.39	74.72	-41.01	5.25	367.33	237.5
Treasury Stock	-	-	-	-29.97	-	-
Comprehensive Income & Other	4.89	4.89	4.89	4.89	-19.97	4.89
Total Common Equity	821.53	193.66	77.93	94.21	462.83	357.86
Minority Interest	0.29	0.26	0.17	0.12	0.11	0.06
Shareholders' Equity	821.82	193.92	78.1	94.33	462.94	357.93
Total Liabilities & Equity	1,264	777.66	615.03	513.69	849.63	577.1

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	50.03	333.43	316.32	226.18	204.65	97.81
Net Cash (Debt)	429.87	-157.39	-253.98	-150.87	-17.89	-37.14
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.28	-0.28	-0.45	-0.27	-0.03	-0.06
Filing Date Shares Outstanding	3,421	570.21	562.11	563.05	570.21	577.36
Total Common Shares Outstanding	3,421	570.21	562.11	563.05	570.21	577.36
Working Capital	707.15	163.78	132.42	29.7	366.44	270.04
Book Value Per Share	0.24	0.34	0.14	0.17	0.81	0.62
Tangible Book Value	795.04	166.95	51.19	67	410.61	311.16
Tangible Book Value Per Share	0.23	0.29	0.09	0.12	0.72	0.54
Land	3.52	3.52	3.52	3.52	3.52	3.52
Buildings	26.59	26.2	16.91	16.91	16.37	16.37
Machinery	93.82	88.91	57.02	45.7	39.87	34.57
Construction In Progress	-	-	-	-	-	2.73

Data Source: S&P Global Market Intelligence Last updated: Aug 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error